Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001831410-25-000004

Director sold 25,000 shares at an average $8.19 ($204,841)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harmon Cyrus Director 2025-09-16 Sale −10,000 $8.04 $80,400 754,140 D: show line 1 in the form
Harmon Cyrus Director 2025-09-18 Sale −10,000 $8.33 $83,300 744,140 D: show line 2 in the form
Harmon Cyrus Director 2025-09-16 Sale −1,914 $8.08 $15,465 120,114 I: show line 3 in the form
Harmon Cyrus Director 2025-09-18 Sale −3,086 $8.32 $25,676 117,028 I: show line 4 in the form
Open-market sales · 25,000 sh · avg $8.19 · $204,841
Loading xslF345X05/form4-09182025_090901.xml…